Standard Standard

Objective function, lean mass and associated genetic adaptations of the operated leg following total hip arthroplasty. / Okoro, T.; Stewart, C.; Al-Shanti, N. et al.
In: Journal of Musculoskeletal Research, Vol. 18, No. 2, 04.09.2015.

Research output: Contribution to journalArticlepeer-review

HarvardHarvard

Okoro, T, Stewart, C, Al-Shanti, N, Lemmey, AB, Maddison, PJ & Andrew, JG 2015, 'Objective function, lean mass and associated genetic adaptations of the operated leg following total hip arthroplasty', Journal of Musculoskeletal Research, vol. 18, no. 2. https://doi.org/10.1142/S0218957715500074

APA

Okoro, T., Stewart, C., Al-Shanti, N., Lemmey, A. B., Maddison, P. J., & Andrew, J. G. (2015). Objective function, lean mass and associated genetic adaptations of the operated leg following total hip arthroplasty. Journal of Musculoskeletal Research, 18(2). https://doi.org/10.1142/S0218957715500074

CBE

MLA

VancouverVancouver

Okoro T, Stewart C, Al-Shanti N, Lemmey AB, Maddison PJ, Andrew JG. Objective function, lean mass and associated genetic adaptations of the operated leg following total hip arthroplasty. Journal of Musculoskeletal Research. 2015 Sept 4;18(2). doi: 10.1142/S0218957715500074

Author

Okoro, T. ; Stewart, C. ; Al-Shanti, N. et al. / Objective function, lean mass and associated genetic adaptations of the operated leg following total hip arthroplasty. In: Journal of Musculoskeletal Research. 2015 ; Vol. 18, No. 2.

RIS

TY - JOUR

T1 - Objective function, lean mass and associated genetic adaptations of the operated leg following total hip arthroplasty

AU - Okoro, T.

AU - Stewart, C.

AU - Al-Shanti, N.

AU - Lemmey, A.B.

AU - Maddison, P.J.

AU - Andrew, J.G.

PY - 2015/9/4

Y1 - 2015/9/4

N2 - Purpose: To characterize muscle recovery following total hip arthroplasty (THA) combining genetic adaptations in the affected leg with objective function and body composition assessment. Methods: Preoperatively and at six weeks postoperatively, objective function was assessed by: maximal voluntary contraction of the operated leg quadriceps (MVCOLQ) in Newtons (N), 30 s chair sit-to-stand (ST), and six-minute walk test (6MWT), with lean mass of the operated leg estimated by dual energy X-ray absorptiometry (DEXA). Genetic adaptations were assessed from vastus lateralis (VL) biopsies by quantitative polymerase chain reaction (qPCR) analysis of markers of hypertrophy (FOS, calpain2 (CAPN2)), atrophy (20 s proteasome alpha subunit 7 (PSMA7), cathepsin L2 (CTSL2), inflammation (Tumour necrosis factor alpha (TNF-α), Interleukin-6 (IL-6)) and lipid metabolism (lipoprotein lipase, LPL and peroxisome proliferated activated receptor gamma (PPARAG). Results: 14 patients were recruited. At six weeks, no significant differences, relative to preoperative values, were noted in either objective function or leg lean mass. Markers for hypertrophy were increased (FOS +1463%, p = 0.016), with atrophy (PSMA7 -44.8%, p = 0.016; CTSL2 -42.5%, p = 0.050), inflammation (TNF -29.6%, p = 0.023) and lipid metabolism markers showing a decreasing trend (LPL -42.45%, p = 0.016). Conclusion: The initial post-THA intramuscular environment appears supportive of anabolism. However, this is not reflected in objective function or lean mass measures at six weeks, suggesting longer duration may be required for physiological adaptation to occur.

AB - Purpose: To characterize muscle recovery following total hip arthroplasty (THA) combining genetic adaptations in the affected leg with objective function and body composition assessment. Methods: Preoperatively and at six weeks postoperatively, objective function was assessed by: maximal voluntary contraction of the operated leg quadriceps (MVCOLQ) in Newtons (N), 30 s chair sit-to-stand (ST), and six-minute walk test (6MWT), with lean mass of the operated leg estimated by dual energy X-ray absorptiometry (DEXA). Genetic adaptations were assessed from vastus lateralis (VL) biopsies by quantitative polymerase chain reaction (qPCR) analysis of markers of hypertrophy (FOS, calpain2 (CAPN2)), atrophy (20 s proteasome alpha subunit 7 (PSMA7), cathepsin L2 (CTSL2), inflammation (Tumour necrosis factor alpha (TNF-α), Interleukin-6 (IL-6)) and lipid metabolism (lipoprotein lipase, LPL and peroxisome proliferated activated receptor gamma (PPARAG). Results: 14 patients were recruited. At six weeks, no significant differences, relative to preoperative values, were noted in either objective function or leg lean mass. Markers for hypertrophy were increased (FOS +1463%, p = 0.016), with atrophy (PSMA7 -44.8%, p = 0.016; CTSL2 -42.5%, p = 0.050), inflammation (TNF -29.6%, p = 0.023) and lipid metabolism markers showing a decreasing trend (LPL -42.45%, p = 0.016). Conclusion: The initial post-THA intramuscular environment appears supportive of anabolism. However, this is not reflected in objective function or lean mass measures at six weeks, suggesting longer duration may be required for physiological adaptation to occur.

U2 - 10.1142/S0218957715500074

DO - 10.1142/S0218957715500074

M3 - Article

VL - 18

JO - Journal of Musculoskeletal Research

JF - Journal of Musculoskeletal Research

SN - 0218-9577

IS - 2

ER -